Exposome, Pollutants, Biology in the Older Subject: EXPOSAGE
EXPOSAGE
1 other identifier
interventional
400
1 country
1
Brief Summary
Numerous factors, both individual and environmental, can influence aging, an individual's health, and their functional status. However, the understanding of the combined impact of lifestyle-related exposures (e.g., physical activity, diet, sleep) (personal external exposome), exposures to pollutants (environmental external exposome), and their biological responses (internal exposome)-in other words, the impact of the "exposome" on healthy aging-remains limited, particularly in characterizing the molecular mechanisms associated with these interactions. Exposome approaches identifying key exposures and molecular mechanisms could lead to a better understanding of how the environment, interacting with health behaviors, can affect functional status. Thus, the objective of this study is i) to evaluate the links between the external exposome, the internal exposome and the health of older and aging individuals, and ii) to identify biological markers associated with a vulnerable health status in older and aging individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2030
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedStudy Start
First participant enrolled
September 1, 2030
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2031
Study Completion
Last participant's last visit for all outcomes
September 1, 2031
July 1, 2026
June 1, 2026
1 year
June 11, 2026
June 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Frailty (health measure)
Frailty is assessed using the Groningen Frailty Indicator. The scale comprises 15 items. The total score ranges from 0 to 25, with a higher score being worse.
at baseline and 12 months later
Secondary Outcomes (16)
Functional and health status
at baseline and 1 year
Physical functional capacities (health measure)
at baseline and at 12 months
Quality of life (health measure)
at baseline and 12 months
Autonomy (health measure)
at baseline and 12 months
Comorbidity (health measure)
at baseline and 12 months
- +11 more secondary outcomes
Study Arms (1)
Exposome assessment
OTHERInterventions
Visit 1: blood sample, questionnaires on the personal exposome (lifestyle habits (e.g., physical activity, diet, stress) and social characteristics and health status) \| ii) Outpatient assessment: wearing a silicone bracelet for 7 days to measure external environmental exposure to pollutants and quantify physical activity \| iii) Visit 2: 1-year follow-up of health status
Eligibility Criteria
You may qualify if:
- Aged 55 or over
- Affiliated with or beneficiaries of a social security scheme
- Signed the informed consent form •-Persons residing in one of the following municipalities : Antibes, Le Bar-sur-Loup, Berre-les-Alpes, Beuil, Blausasc, Breil-sur-Roya, Cabris, Cannes, Carros, Clans, Contes, Drap, L'Escarène, Escragnolles, Fontan, La Gaude, Gilette, Grasse, Lantosque, Levens, Nice, Peillon, Peymeinade, Saint-André-de-la-Roche, Saint-Etienne-de-Tinée, Sospel, Tourrettes-sur-Loup, Vence, Tende
You may not qualify if:
- patients currently undergoing intensive drug treatment, including chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice - Hopital de Cimiez
Nice, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2026
First Posted
July 1, 2026
Study Start (Estimated)
September 1, 2030
Primary Completion (Estimated)
September 1, 2031
Study Completion (Estimated)
September 1, 2031
Last Updated
July 1, 2026
Record last verified: 2026-06